參考資料

  1. Wong CY. Gastro-esophageal reflux disease: Optimizing proton pump inhibitor therapy to improve symptom control. JSPHK 2014;6:1-2.
  2. Wong WM, et al. Prevalence, clinical spectrum and health care utilization of gastro-oesophageal reflux disease in a Chinese population: a population-based study. Aliment Pharmacol Ther. 2003;18(6):595-604.
  3. Lowe RC. Medical management of gastroesophageal reflux disease. Goyal & Shaker GI Motility online. Accessed 19 March, 2019, at https://www.nature.com/gimo/contents/pt1/full/gimo54.html
  4. Ranjitkar S, Kaidonis J, Smales R. Gastroesophageal Reflux Disease and Tooth Erosion. Int J Dent. 2012;2012:1-10. doi:10.1155/2012/479850
  5. Tan PY, et al. Gastroesophageal Reflux Disease: Cross-Sectional Study Demonstrating Rising Prevalence in a Chinese Population. J Clin Gastroenterol. 2016;50(1):e1-7.
  6. Menezes MA, et al. Pathophysiology of Gastroesophageal Reflux Disease. World J Surg. 2017;41(7):1666-1671.
  7. Hunt R, et al. World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease. J Clin Gastroenterol. 2017;51(6):467-478.
  8. Yang XJ, Jiang HM, Hou XH, et al. Anxiety and depression in patients with gastroesophageal reflux disease and their effect on quality of life. World J Gastroenterol. 2015;21(14):4302-9.
  9. Health Action. Issue 148. March 2019.
  10. Cleveland Clinic. Long-Term Complications of Gastroesophageal Reflux Disease (GERD). Accessed 28 February, 2019, at https://my.clevelandclinic.org/health/articles/9615-long-term-complications-of-gastroesophageal-reflux-disease-gerd.
  11. Mayo Clinic. Gastroesophageal reflux disease (GERD) Symptoms & causes. Accessed 19 March, 2019, at https://www.mayoclinic.org/diseases-conditions/gerd/symptoms-causes/syc-20361940.
  12. Katz PO, Gerson LB, Vela MF. Guidelines for the diagnosis and management of gastroesophageal reflux disease. Am J Gastroenterol. 2013;108(3):308-28;quiz 329.
  13. Mayo Clinic. Gastroesophageal reflux disease (GERD) Diagnosis & treatment. Accessed 19 March, 2019, at https://www.mayoclinic.org/diseases-conditions/gerd/diagnosis-treatment/drc-20361959.
  14. NHS. Antacids. Accessed 19 March, 2019, https://www.nhs.uk/conditions/antacids/.
  15. Mayo Clinic. Histamine H2 Antagonist (Oral Route, Injection Route, Intravenous Route). Accessed 19 March, 2019, at https://www.mayoclinic.org/drugs-supplements/histamine-h2-antagonist-oral -route-injection-route-intravenous-route/proper-use/drg-20068584.
  16. Fock KM, Talley NJ, Fass R, et al. Asia-Pacific consensus on the management of gastroesophageal reflux disease: update. J Gastroenterol Hepatol. 2008;23(1):8-22.
  17. Lee RD, et al. Aliment Pharmacol Ther 2009 ;29(8) :824-33
  18. Medscape. Laparoscopic Nissen Fundoplication. Accessed 10 December, 2019 at https://emedicine.medscape.com/article/1892517-overview
  19. Fass R, Johnson DA, Orr WC, et al. The effect of dexlansoprazole MR on nocturnal heartburn and GERD-related sleep disturbances in patients with symptomatic GERD. Am J Gastroenterol. 2011;106(3):421-31.
  20. Wong WM, Lam KF, Lai KC, et al. A validated symptoms questionnaire (Chinese GERDQ) for the diagnosis of gastro-oesophageal reflux disease in the Chinese population. Aliment Pharmacol Ther. 2003;17(11):1407-13.